Motz; Manfred

Patent Applications and Registrations

Patent applications and USPTO patent grants for Motz; Manfred.The latest application filed is for "antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy".

Company Profile

0.10.9

Motz; Manfred - Munich N/A DE
Motz; Manfred - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy Grant 10,669,350 - Bauer , et al.	2020-06-02
Antigen-binding Constructs That Bind To And Inhibit Catalase And/or Superoxide Dismutase As Well As Pharmaceutical Compositions Containing Them For Tumor Therapy App 20180002445 - BAUER; Georg ; et al.	2018-01-04
Method for determining early HCV seroconversion App 20090098528 - Seidel; Christoph ; et al.	2009-04-16
Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof Grant 7,476,498 - Motz , et al. January 13, 2	2009-01-13
Method for determining early HCV seroconversion Grant 7,122,302 - Seidel , et al. October 17, 2	2006-10-17
Immunologically active proteins from Borrelia burgdorferi Grant 7,083,792 - Fuchs , et al. August 1, 2	2006-08-01
Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof App 20060057563 - Motz; Manfred ; et al.	2006-03-16
Method for determining early HCV seroconversion App 20050095584 - Seidel, Christoph ; et al.	2005-05-05
Immunologically active proteins from borrelia burgdorferi App 20040253611 - Fuchs, Renate ; et al.	2004-12-16
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines Grant 6,808,711 - Motz , et al. October 26, 2	2004-10-26
Immunologically active proteins from Borrelia burgdorferi Grant 6,753,183 - Fuchs , et al. June 22, 2	2004-06-22
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines App 20030185859 - Motz, Manfred ; et al.	2003-10-02
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines Grant 6,610,301 - Motz , et al. August 26, 2	2003-08-26
Immunologically active proteins from borrelia burgdorferi App 20030157562 - Fuchs, Renate ; et al.	2003-08-21
Method for determining early HCV seroconversion App 20030129582 - Seidel, Christoph ; et al.	2003-07-10
Recombinant antigen from the NS3 region of the hepatitis C virus Grant 6,306,579 - Seidel , et al. October 23, 2	2001-10-23
Recombinant antigen from the NS3 region of the hepatitis C virus Grant 6,096,319 - Seidel , et al. August 1, 2	2000-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.